Botanical species · safety record

Chondrodendron tomentosum

The EFSA Compendium of Botanicals holds 8 constituent measurements for Chondrodendron tomentosum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chondrodendron tomentosum Ruiz & Pav.

8Constituent measurements

0Safety records

4Cited sources

2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Chondrodendron tomentosum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Unspecified	Solvent extraction	—	Chromatographic tests	Resolve DOI
Alkaloids	Bark	Solvent extraction	2.2 Milligram/100 gram	Gaschromatography (GC)	Resolve DOI
Alkaloids	Bark	Solvent extraction	0.25 Percent	Gaschromatography (GC)	Resolve DOI
Chondrocurine	Bark	Solvent extraction	0.485 Milligram/100 gram	Gaschromatography (GC)	Resolve DOI
Cycleanine	Bark	Solvent extraction	0.757 Milligram/100 gram	Gaschromatography (GC)	Resolve DOI
D-isochondodendrine	Stem / stalk	Solvent extraction	—	Chromatographic tests	Resolve DOI
D-tubocurarine	Stem / stalk	Solvent extraction	—	Chromatographic tests	Resolve DOI
Isoquinoline alkaloids	Unspecified	—	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gonzalez-Coloma, Azucena., Reina, Matias., Saenz, Claudia., Lacret, Rodney., Ruiz-Mesia, Lastenia., Aran, Vicente J., Sanz, Jesus., Martinez-Diaz, Rafael A. Antileishmanial, antitrypanosomal, and cytotoxic screening of ethnopharmacologically selected Peruvian plants . Parasitology research, 2012, vol. 110, no. 4, p. 1381-1392. DOI
DUTCHER, JD. CURARE ALKALOIDS FROM CHONDODENDRON-TOMENTOSUM, RUIZ AND PAVON. Journal of the american chemical society, 1946, vol. 68, no. 3, p. 419-424. DOI
DUTCHER, JD. THE ISOLATION AND IDENTIFICATION OF ADDITIONAL PHYSIOLOGICALLY ACTIVE ALKALOIDS IN EXTRACTS OF CHONDODENDRON-TOMENTOSUM RUIZ AND PAVON . Annals of the new york academy of sciences, 1951, vol. 54, no. 3, p. 326-356. DOI
Salakhutdinov, N. F., Tolstikov, A. Diquaternized Curarelike Myorelaxants: Structure and Biological Activity. Mini-reviews in medicinal chemistry, 2010, vol. 10, no. 13, p. 1248-1262.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature